Kári Stefánsson, MD, Dr Med


Kári StefánssonKári Stefánsson, M.D., Dr. Med. founded deCODE in August 1996. Dr. Stefánsson was previously a professor of Neurology, Neuropathology and Neuroscience at Harvard University and Director of Neuropathology at Beth Israel Hospital in Boston, Massachusetts. From 1983 to 1993, he held faculty positions in Neurology, Neuropathology and Neurosciences at the University of Chicago. Dr. Stefánsson received his M.D. and Dr. Med. from the University of Iceland and is board-certified in neurology and neuropathology in the United States. Dr. Stefansson is recognized as a leading figure in human genetics. He has shaped deCODE’s scientific approach and been actively engaged in leading its gene discovery work, serving as senior author on most of the company’s publications in major scientific journals.

Curriculum Vitae

Unnur Thorsteinsdottir, Ph.D.

Vice President of Research

unnur_thorsteinsdottirUnnur received her Bachelor of Science (BSc) degree in biology from the University of Iceland, and completed a PhD degree in genetics at the University of British Columbia in 1997. She was a postdoctoral fellow in the Laboratory of Experimental Hemato-Oncology and Gene Therapy Institut de Recherches Cliniques de Montreal, and joined deCODE in 2000. Since 2003 she has led deCODE’s population genomics work, and has also pursued gene discovery work in various cancers.

C. Augustine Kong, Ph.D.

Vice President of Statistics

Augustin-KongC. Augustine Kong, Ph.D., has led deCODE’s statistics team since 1996. Prior to joining deCODE, he served on the faculty of the University of Chicago. Dr. Kong received his Ph.D. in statistics from Harvard University in 1986.